Condition: Carpal Tunnel Syndrome (CTS) · Sponsor: Emre Şenocak
The study plans to include a total of 60 patients diagnosed with carpal tunnel syndrome. Patients will be divided into two groups according to the treatment they receive. One group will receive only paraffin treatment, while the other group will receive only ESWT treatment. ESWT will be applied for a total of 5 sessions. Paraffin will be applied for a total of 10 sessions. As assessment tools; * Measurement of median nerve thickness with ultrasound * Electromyography * Visual Analog Scale * Short Form-36 Evaluations will be made twice by a specialist physician before and after the treatments.
This description comes directly from the study's public registry record.
Esra Sonbahar Bolat, Physician · +9005052686709 · esra.sonbahar@hotmail.com
Always discuss trial participation with your own doctor first.
| Baltalimani Metin Sabanci Bone Diseases Training and Research Hospita | Istanbul, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07167667